Is HWA 486 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use HWA 486? Is HWA 486 safe for nursing mother and child? Does HWA 486 extracts into breast milk? Does HWA 486 has any long term or short term side effects on infants? Can HWA 486 influence milk supply or can HWA 486 decrease milk supply in lactating mothers?
HWA 486 lactation summary
- DrLact safety Score for HWA 486 is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of HWA 486 may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that HWA 486 may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using HWA 486 .
- Usage of HWA 486 is in contradiction to breastfeeding hence if it is must to use HWA 486 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About HWA 486 usage in lactation
We are working on a comment for this product.
Answer by DrLact: About HWA 486 usage in lactation
No information is available on the use of HWA 486 during breastfeeding, so an alternate drug may be preferred, especially while nursing a newborn or preterm infant.[1][2]
Alternate Drugs
Certolizumab Pegol(Safe)
Auranofin(Low Risk)
Adalimumab(Safe)
Methotrexate(Low Risk)
Infliximab(Safe)
Leflunomide(Dangerous)
Sulfasalazine(Safe)
Tocilizumab(Low Risk)
Hydroxychloroquine(Safe)
Chloroquine(Safe)
Anakinra(Low Risk)
Abatacept(Low Risk)
Penicillamine(Low Risk)
Rituximab(Low Risk)
Etanercept(Safe)
Dimethyl fumarate(Low Risk)
Cyclosporine(Safe)
Azathioprine(Safe)
Pimecrolimus(Low Risk)
Methotrexate(Low Risk)
Everolimus(Unsafe)
Leflunomide(Dangerous)
Fluorouracil(Dangerous)
Tacrolimus(Safe)
Alemtuzumab(Low Risk)
Mercaptopurine(Safe)
Gemcitabine(Dangerous)
Fingolimod(Unsafe)
Sirolimus(Unsafe)
Cladribine(Dangerous)